Seminary:
Resistance of the Plasmodium falciparum and Plasmodium vivax Monitoring to Antimalarials in Rondônia and search for new schizontocidal blood and tissue for control and treatment of disease.
Chloroquine (CQ), a cost effective antimalarial drug with a relatively good safety profile and therapeutic index, is no longer used by itself to treat patients with Plasmodium falciparum due to CQ-resistant strains. P. vivax, representing over 90% of malaria cases in Brazil, despite reported resistance, is treated with CQ as well as with primaquine to block malaria transmission and avoid late P. vivax malaria relapses. Resistance to CQ and other antimalarial drugs influences malaria control, thus monitoring resistance phenotype by parasite genotyping is helpful in endemic areas.
Date: September 11th
Time: 13:30
Local: IFSC campus II (sala 1, piso 1)
Speaker: Anna Caroline Campos Aguiar (Fio Cruz MG)